Recent Comments

Psychologists Study Zero-Gravity Effects on the Human Brain (1)
computer user 14 wrote: So your doing this experiment to see if zero-g hel… [More]
Insertion of tiny heart pump without surgery (1)
Md. Saif Uddin wrote: My father is aged 57 and has TVD (Tripple Vessel D… [More]
Saffron could stop blindness and cure eye disease (2)
Marilyn wrote: Do you know where I could find this article in Fre… [More]
Department of Health announces adult autism strategy (1)
Cindy Wigglesworth wrote: My 18 year old son has Asperger's, ADHD, and anger… [More]
Concerns raised over safety of 'electronic cigarettes' (7)
carlo wrote: I had a little sore throat too. I think it was bec… [More]
Skin specialists issue warning about tan jab (1)
Melanotan wrote: Because of the side effects that they found out in… [More]
American Fertility Association to educate gay and lesbian community on gestational surrogacy (1)
Jose Luis Hernandez wrote: We are a couple that have been together for 16 yea… [More]

<< MarketsandMarkets offers new report on the global minimally invasive/ non invasive market | Ten of ChemBridge's screening libraries available through CDD database >>

Celgene to collaborate with PTC on advancing drug discovery efforts

3. September 2009 07:22

PTC Therapeutics, Inc. (PTC) today announced that Celgene Corporation has exercised its option to collaborate on advancing drug discovery efforts on an oncology target addressed through the application of PTC's GEMS(TM) (Gene Expression Modulation by Small-molecules) technology.

In September 2007, Celgene made a $20 million equity investment in PTC, which included an option for an exclusive research agreement. Under the terms of the research collaboration agreement, PTC will receive substantial milestone payments for achieving certain discovery, development, regulatory and commercial objectives.

"Celgene's decision to exercise the research option is a wonderful endorsement of our GEMS technology. Celgene is widely recognized for developing novel therapies in areas of high unmet medical need and we look forward to working together to advance this project," said Stuart Peltz, Ph.D., president and CEO of PTC Therapeutics.

http://www.ptcbio.com/

ce073ef0-3b14-4d39-abac-dabb2a857cf4|0|.0

Posted in: Pharmaceutical News

Tags: Exercise, Gene Expression, Investment, Muscular Dystrophy, Oncology, Pfizer

Pfizer reports final results from randomized Phase 3 trial of SutentPfizer Inc. today announced final results from a randomized Phase 3 trial of Sutent (sunitinib malat...Satellites used for European health early warning and epidemiology exerciseAn earthquake has just shaken the Greek island. Damage is widespread and all conventional, terrestri...More than 15 percent of our genes are mobilized to defend against microbial attacksThe body's overwhelming genetic defense, which has implications for the survival of patients who are...Positron emission tomography (PET) imaging can identify effectiveness of chemotherapy early in high-risk breast cancer patientsThe effectiveness of chemotherapy in patients with advanced breast cancer can be evaluated earlier b...Fourth gene found for distal muscular dystrophyMDA grantees Peter Hedera, a neurologist at Vanderbilt University in Nashville, Tenn., and Nigel Lai...Bionomics files novel angiogenesis genes patentBionomics Limited has announced that it had filed a further international patent application that co...

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment

Quirky Comment Title
Name*
E-mail* (Will show your Gravatar icon)
Country Country flag

b i u quote

Comment
Preview

Notify me when new comments are added

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Celgene to collaborate with PTC on advancing drug discovery efforts

Recent Articles

Free!

Recent Comments

Twitter

Information

Celgene to collaborate with PTC on advancing drug discovery efforts

Medical News Cloud

Recent Articles